Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or Flutter

This publication has 25 references indexed in Scilit:

• To prolong refractoriness or to delay conduction (or both)?
  European Heart Journal, 1992
• Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observations on the role of trial design and implications of drug-related mortality
  American Heart Journal, 1992
• Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter
  The American Journal of Cardiology, 1992
• Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
  Circulation, 1990
• Rate-Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK-68,798
  Journal of Cardiovascular Pharmacology, 1990
• Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.
  The Journal of general physiology, 1990
• When is QT prolongation antiarrhythmic and when is it proarrhythmic?
  The American Journal of Cardiology, 1989
• Digoxin for Converting Recent-Onset Atrial Fibrillation to Sinus Rhythm
  Annals of Internal Medicine, 1987
• Control of cardiac arrhythmias by selective lengthening of repolarization: Theoretic considerations and clinical observations
  American Heart Journal, 1985
• A Comparison of Some Approximate Confidence Intervals for the Binomial Parameter
  Journal of the American Statistical Association, 1979